Catalyst Pharmaceuticals, Inc. (CPRX): Price and Financial Metrics

Catalyst Pharmaceuticals, Inc. (CPRX)

Today's Latest Price: $4.31 USD

0.00 (0.00%)

Updated May 29 4:00pm

Add CPRX to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

CPRX Stock Summary

  • The ratio of debt to operating expenses for Catalyst Pharmaceuticals Inc is higher than it is for about merely 5.73% of US stocks.
  • Over the past twelve months, CPRX has reported earnings growth of -255.76%, putting it ahead of merely 6.56% of US stocks in our set.
  • Revenue growth over the past 12 months for Catalyst Pharmaceuticals Inc comes in at 818.99%, a number that bests 99.1% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Catalyst Pharmaceuticals Inc are DIOD, VNDA, DGII, CAMT, and VIOT.
  • CPRX's SEC filings can be seen here. And to visit Catalyst Pharmaceuticals Inc's official web site, go to
CPRX Daily Price Range
CPRX 52-Week Price Range

CPRX Stock Price Chart More Charts

CPRX Price/Volume Stats

Current price $4.31 52-week high $7.67
Prev. close $4.31 52-week low $2.55
Day low $4.16 Volume 1,884,426
Day high $4.37 Avg. volume 2,048,757
50-day MA $4.31 Dividend yield N/A
200-day MA $4.69 Market Cap 445.72M

Catalyst Pharmaceuticals, Inc. (CPRX) Company Bio

Catalyst Pharmaceuticals focuses on the development and commercialization of prescription drugs targeting rare neurological diseases and disorders. The company was founded in 2002 and is based in Coral Gables, Florida.

CPRX Latest News Stream

Event/TimeNews Detail
Loading, please wait...

CPRX Latest Social Stream

Loading social stream, please wait...

View Full CPRX Social Stream

Latest CPRX News From Around the Web

Below are the latest news stories about Catalyst Pharmaceuticals Inc that investors may wish to consider to help them evaluate CPRX as an investment opportunity.

What Does The Future Hold For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)? These Analysts Have Been Cutting Their Estimates

One thing we could say about the analysts on Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - they aren't optimistic...

Yahoo | May 17, 2020

Catalyst Pharmaceuticals, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Last week, you might have seen that Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) released its quarterly result to the...

Yahoo | May 14, 2020

Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings Estimates

Catalyst (CPRX) delivered earnings and revenue surprises of 11.11% and -8.02%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 11, 2020

Catalyst Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update

Firdapse® Q1 2020 Net Revenues of $29.1 MillionFirst Quarter 2020 GAAP Net Income of $10.4 MillionCatalyst Withdraws Previous 2020 Revenue Guidance Due to COVID-19.

Yahoo | May 11, 2020

Catalyst Pharmaceuticals to Hold First Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, May 12th, 2020

Catalyst Pharmaceuticals, Inc. (Catalyst) (CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced that it will release first quarter 2020 financial results after market close on Monday, May 11, 2020. Further, Catalyst management will host an investment-community conference call at 8:30 a.m. ET on Tuesday, May 12, 2020 to discuss the financial results and to provide a corporate update. Investors who wish to participate in the conference call may do so by dialing (877) 407-8912 for domestic and Canadian callers or (201) 689-8059 for international callers.

Yahoo | May 4, 2020

Read More 'CPRX' Stories Here

CPRX Price Returns

1-mo -10.40%
3-mo 2.38%
6-mo -7.11%
1-year 26.76%
3-year 99.54%
5-year 9.11%
YTD 14.93%
2019 95.31%
2018 -50.90%
2017 272.38%
2016 -57.14%
2015 -17.51%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8789 seconds.